BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), Reports First Quarter 2k19 Financial Results and Provides Corporate Update

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended March 31, 2k19 and provided a…

View More BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), Reports First Quarter 2k19 Financial Results and Provides Corporate Update

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), Reports 38percent Revenue Growth In The 1Q

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced  1Q  2k19 financial results with…

View More Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), Reports 38percent Revenue Growth In The 1Q

Leju Holdings Limited (“Leju” or the “Company”) (NYSE: LEJU), Reports Q12k19 Results

Leju Holdings Limited (“Leju” or the “Company”) (NYSE: LEJU), a leading online-to-offline (“O2O”) real estate services provider in China, today announced its unaudited financial results for the fiscal…

View More Leju Holdings Limited (“Leju” or the “Company”) (NYSE: LEJU), Reports Q12k19 Results

Sunlands Technology Group (NYSE: STG), Announces Unaudited Q12019 Financial Results

Net revenues increased by 38.800percent year-over-year Gross billings (non-GAAP) decreased by 28.600percent year-over-year New student enrollments[1] decreased by 34.200percent year-over-year Sunlands Technology Group (NYSE: STG) (“Sunlands” or the…

View More Sunlands Technology Group (NYSE: STG), Announces Unaudited Q12019 Financial Results